BIOSPECIMEN PROCESSING CENTER (BPC) - EARLY ONSET MALIGNANCIES INITIATIVE

本任务令为早发性恶性肿瘤倡议(EOMI)提供支持。EOMI是CCG和癌症预防部门的NCI社区肿瘤学研究计划(NCORP)合作的倡议，旨在调查某些种族和民族人口在早期患癌症的风险增加的原因，EOMI将专注于在某些少数群体中较早发病、发病率较高且通常更具侵袭性的六种癌症类型。癌症基因组学中心(CCG)生物样品处理中心(BPC)通过提供以下服务支持EOMI基因组学项目：生物样品和相关数据采购、生物样品管理和生物库操作、生物样品组织学审查、将生物样品加工成分子分析物，以及生物样品和分析物分配。

This Task Order provides support to the Early Onset Malignancies Initiative (EOMI). The EOMI is a collaborative initiative between CCG and the Division of Cancer Prevention’s NCI Community Oncology Research Program (NCORP) investigating why certain racial and ethnic populations are at increased risk of developing cancer at an early age, The EOMI will focus on six cancer types that in certain minority populations develop at an earlier age, occur in higher rates, and are typically more aggressive. The Center for Cancer Genomics (CCG) Biospecimen Processing Center (BPC) supports the EOMI genomics projects by providing the following services: Biospecimen and associated Data Procurement, Biospecimen Management and Biorepository Operations, Biospecimen Histological Review, Biospecimen Processing into Molecular Analytes, and Biospecimen and Analyte Distribution.